111 related articles for article (PubMed ID: 15808648)
1. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury.
Suleiman M; Cury PM; Pestana JO; Burdmann EA; Bueno V
Transplant Proc; 2005; 37(1):373-4. PubMed ID: 15808648
[TBL] [Abstract][Full Text] [Related]
2. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration.
Kaudel CP; Frink M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; van Griensven M; Winkler M
Transplant Proc; 2007 Mar; 39(2):499-502. PubMed ID: 17362767
[TBL] [Abstract][Full Text] [Related]
3. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice.
Kaudel CP; Schmiddem U; Frink M; Bergmann S; Pape HC; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2006 Apr; 38(3):679-81. PubMed ID: 16647442
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury.
da Silva LB; Palma PV; Cury PM; Bueno V
Int Immunopharmacol; 2007 Dec; 7(13):1609-16. PubMed ID: 17996670
[TBL] [Abstract][Full Text] [Related]
5. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs.
Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M
J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822
[TBL] [Abstract][Full Text] [Related]
6. FTY720 impairs necrosis development after ischemia-reperfusion injury.
Oliveira CM; Borra RC; Franco M; Schor N; Silva HT; Pestana JO; Bueno V
Transplant Proc; 2004 May; 36(4):854-6. PubMed ID: 15194292
[TBL] [Abstract][Full Text] [Related]
7. Prolonged administration of FTY720 does not cause renal toxicity in mice.
Galvão VR; Ginoza M; Franco M; Burdmann EA; Bueno V
Transplant Proc; 2005; 37(1):112-3. PubMed ID: 15808564
[TBL] [Abstract][Full Text] [Related]
8. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
[TBL] [Abstract][Full Text] [Related]
9. TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720.
Pedregosa JF; Haidar AA; Hirata AE; Franco M; Gomes GN; Bueno V
Int Immunopharmacol; 2011 Sep; 11(9):1311-8. PubMed ID: 21571100
[TBL] [Abstract][Full Text] [Related]
10. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
12. FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model.
Kaudel CP; Frink M; van Griensven M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2007 Mar; 39(2):493-8. PubMed ID: 17362766
[TBL] [Abstract][Full Text] [Related]
13. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
14. CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury.
Kim MG; Lee SY; Ko YS; Lee HY; Jo SK; Cho WY; Kim HK
Nephrol Dial Transplant; 2011 Jan; 26(1):111-24. PubMed ID: 20702533
[TBL] [Abstract][Full Text] [Related]
15. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
16. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
[TBL] [Abstract][Full Text] [Related]
17. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
18. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
[TBL] [Abstract][Full Text] [Related]
19. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
20. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
